CATEGORY
DNA Vaccines
Beroe LiVE.Ai™
AI-powered self-service platform for all your sourcing decision needs across 1,600+ categories llike DNA Vaccines.
Market Data, Sourcing & Supplier Intelligence, and Price & Cost Benchmarking.
Category Alerts
Touchlight and Pfizer have signed a patent licence agreement for the use of Touchlight dbDNA in the development of Pfizer mRNA-based vaccines, therapeutics, and gene therapies.
July 21, 2022Touchlight and Pfizer have signed a patent licence agreement for the use of Touchlight dbDNA in the development of Pfizer mRNA-based vaccines, therapeutics, and gene therapies.
July 21, 2022Touchlight and Pfizer have signed a patent licence agreement for the use of Touchlight dbDNA in the development of Pfizer mRNA-based vaccines, therapeutics, and gene therapies.
July 21, 2022Become a Beroe LiVE.Ai™ Subscriber to receive proactive alerts on DNA Vaccines
DNA Vaccines Market Monitoring Dashboard
Understand the correlation between costs, margins, and prices impacting your category on a real time basis on Beroe LiVE.Ai™
DNA Vaccines Industry Benchmarks
Savings Achieved
(in %)
The average annual savings achieved in DNA Vaccines category is 5.40%
Payment Terms
(in days)
The industry average payment terms in DNA Vaccines category for the current quarter is 73.4 days
Compare your category performance against peers and industry benchmarks across 20+ parameters on Beroe LiVE.Ai™
Category Strategy and Flexibility
Engagement Model
Supply Assurance
Sourcing Process
Supplier Type
Pricing Model
Contract Length
SLAs/KPIs
Lead Time
Supplier Diversity
Targeted Savings
Risk Mitigation
Financial Risk
Sanctions
AMEs
Geopolitical Risk
Cost Optimization
Price per Unit Competitiveness
Specification Leanness
Minimum Order Quality
Payment Terms
Inventory Control
The World’s first Digital Market Analyst
Abi, the AI-powered digital assistant brings together data, insights, and intelligence for faster answers to sourcing questions
DNA Vaccines Suppliers

Find the right-fit dna vaccines supplier for your specific business needs and filter by location, industry, category, revenue, certifications, and more on Beroe LiVE.Ai™.



Use the DNA Vaccines market, supplier and price information for category strategy creation and Quaterly Business Reviews (QRBs)
DNA Vaccines market report transcript
DNA Vaccines Global Market Outlook:
Market Growth:
CAGR Growth Rate: 26–28 percent between 2019 and 2025.
2019 Market Value: $1.2 billion.
Market Drivers:
- Rising prevalence of cancer and infectious diseases
- Technical expertise and large-scale manufacturing scalability
- Strategic collaborations between pharma and ARO
- Advances in delivery mechanism of DNA vaccines through nanotechnology
Porter's Analysis on DNA Vaccines
Supplier Power
- Supplier understanding of manufacturing synthetic DNA, pDNA, and developing a preprimary DNA platform gives them an upper hand. Also, there is a huge FTE rate gap among Europe (except eastern Europe) and the US-based suppliers from their counterparts in India and China
Barriers to New Entrants
- Expertise, technology, and cost are the components driving the category in general, so any new entrant with a particular expertise in a therapeutic area or with adoption of new technology, start working as an independent entity
- Many of the suppliers are an offshoot of the bigger enterprises
Intensity of Rivalry
- The DNA vaccine market is a fragmented in veterinary medicine, dominated by tier-1 companies, while the human DNA vaccine market is still at its infancy and dominated by niche players and research institutes
Threat of Substitutes
- Other vaccine development platforms: Alternative vaccine development platforms for instance those that are mRNA based, GreVac (TM), a genetic platform that can expedite the vaccine delivery and production, Tonix’s proprietary horsepox vaccine platform, etc., could hamper this particular market
Buyer Power
-
Pharma companies are leveraging low- cost countries (mostly, India and China) to consolidate on services, like custom synthesis, analytical testing, and manufacturing. Lower cost and process efficiency are given the highest priority in this type of outsourcing. FFS or FTEs are the most adopted contract models for this type of outsourcing